Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEJAX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,532
Award facts
- Contract value 100% obligated
- $25,532.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,532.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on January 27, 2026, with an ultimate completion date of January 28, 2026, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency. The delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group has been registered in the System for Award Management since 2001 and maintains an extensive product portfolio including branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy through which the Defense Logistics Agency establishes multiple regional prime vendor contractors to supply recurring pharmaceutical and medical consumable needs for military healthcare facilities worldwide. DMS Pharmaceutical Group's single-award Indefinite Delivery Contract under PPV-G GEN V, designated SPE2DR and awarded on November 13, 2025, has a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. The company's demonstrated performance across numerous delivery orders for specialized pharmaceuticals, including oncology treatments, biologics, vaccines, and emergency medications, positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEJAX?
SPE2DU26FEJAX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DU26FEJAX worth?
The government has obligated $25,532 on SPE2DU26FEJAX.
Is contract SPE2DU26FEJAX an order under another contract?
Yes. SPE2DU26FEJAX is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEJAX competed?
The extent of competition for SPE2DU26FEJAX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award